ARUK 2022 | Potential of targeting the gut microbiome to treat Alzheimer’s disease

Investigating the role of the gut microbiome in the development of Alzheimer’s disease (AD) has been a large point of interest for AD research in recent years. Edina Silajdzic, PhD, King’s College London, London, UK, discusses the potential of altering the gut microbiome, using lifestyle changes or medications, to treat or prevent the development of AD. This interview took place at the Alzheimer’s Research UK Conference 2022 in Brighton, UK.